NCT04388878View on ClinicalTrials.gov

Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

June 21, 2022

Study Completion Date

June 21, 2022

Conditions
Healthy
Interventions
DRUG

PF-07054894

Participants will receive oral ascending doses

DRUG

Placebo

Participants will receive matching placebo

Trial Locations (1)

B-1070

Brussels Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04388878 - Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants | Biotech Hunter | Biotech Hunter